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Abstract: Immunocontraceptive vaccines have shown some promise for fertility control of 
white-tailed deer (Odocoileus virginianus) in urban and suburban habitats where traditional 
methods of population control may not be applicable. Currently, the only contraceptive 
vaccine approved by the U.S. Environmental Protection Agency for use in white-tailed deer 
is GonaConTM Immunocontraceptive Vaccine, but it is registered for use via hand-injection 
only. It has been suggested that remote-delivery of immunocontraceptives would be more 
cost-effective than hand-injection, but there is the potential for incomplete injection from a 
syringe-dart. Therefore, the purpose of our research was to: (1) conduct a dart configuration 
assessment trial to determine the ideal syringe-dart configuration for remote-delivery of 
GonaCon to white-tailed deer and (2) use the determined syringe-dart configuration in a 
subsequent trial to evaluate the vaccine efficacy when administered to female white-tailed 
deer via hand-injection versus syringe-dart. We saw comparable results with regard to 
vaccine dispersal during the dart configuration assessment and the efficacy trial; syringe-
dart injected deer presented vaccine deposits and reaction sites both subcutaneously and 
intramuscularly, whereas, hand-injected deer presented vaccine deposits and reaction sites 
only intramuscularly. One year after administration, 4 of 5 deer treated with syringe-darts 
were pregnant, compared to 3 of 6 deer that received hand-injections. Anti-GnRH titers were 
negatively related to pregnancy status. We did not observe a high level of vaccine efficacy 
with the syringe-dart delivery method we used. Therefore, we recommend further research of 
syringe-dart delivery of GonaCon with a larger sample size where the vaccine is deployed in 
a single bolus similar to a hand-injected presentation. 
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Dense populations of white-tailed deer 
(Odocoileus virginianus) coupled with urban 
and suburban expansion have led to increased 
human–deer interactions. When negative, these 
interactions often result in significant economic 
losses resulting from deer–vehicle collisions 
(DVCs), tick-borne pathogens, and landscape 
damage (DeNicola et al. 2000).  
DeNicola and Williams (2008) demonstrated 
that reducing local deer densities can 
significantly reduce DVCs. Lowering deer 
densities may also reduce the incidence of Lyme 
disease, because there is a positive correlation 
between white-tailed deer and blacklegged tick 
(Ixodes scapularis) abundance (Stafford 2004, 
Kilpatrick et al. 2014). The recommended deer 
density for the reduction of blacklegged ticks 
and associated occurrences of Lyme disease 
is <8 deer/km2 (Rand et al. 2003). Low deer 
densities may also reduce damage to personal 
property such as landscaping and gardens 
(DeNicola et al. 2000).
Historically, lethal removal methods (i.e., 
sharpshooting, hunting, or trap and euthanasia) 
have been the accepted action of management 
for deer population reduction (Williams et al. 
2013). However, when suburban communities 
are faced with the need to lower deer densities, 
nonlethal control options are often preferred 
because of legality, safety concerns, and 
social attitudes related to lethal management 
(McCullough et al. 1997). The primary methods 
for nonlethal reduction of deer populations are 
translocation and fertility control. Translocated 
deer have low survival rates due to capture 
myopathy, DVCs, and losses to hunters (Óbryan 
266 Human–Wildlife Interactions 9(2)
and McCullough 1985, Jones and 
Witham 1990). Even if survival rates 
were increased, relocating deer is 
usually not an option because of 
both cost and legal issues concerning 
the spread of pathogens (Conover 
2002). 
Among nonsurgical fertility 
methods of control, immuno-
contraceptive vaccines have shown 
the most promise (Massei and Cowan 
2014). Treatments with porcine 
zona pellucida (PZP) vaccines have 
reduced deer densities (Rutberg 
et al. 2013a, b). However, PZP is 
not registered for use in deer, and 
it allows females to have repeated 
estrous cycles, which may cause 
more males to move into females’ 
home ranges, potentially leading to 
increases in DVCs and damage to 
ornamental plantings (Boulanger 
et al. 2012, 2014). Deer may also suffer 
physiological stress as a result of the extended 
breeding season caused by PZP, (Killian and 
Miller 2000).
GonaConTM is the only immunocontraceptive 
vaccine registered by the U.S. Environmental 
Protection Agency (EPA) for use in deer, and 
its labeling requires administration by hand-
injection (EPA Reg. No. 56228-40). Unlike 
PZP, GonaCon suppresses the secretion of 
reproductive hormones, thus, preventing 
female deer from ovulating or coming into 
estrus (Miller et al. 2004). GonaCon in single-
shot form was shown to be 88% and 47% effective 
during the first and second years, respectively, 
in female white-tailed deer (Gionfriddo et al. 
2009). Treatment of female deer with GonaCon 
via hand-injection causes no adverse effects on 
mobility or general health of deer. The only 
adverse reactions documented in female deer 
have been intramuscular injection-site lesions 
(Gionfriddo et al. 2011). 
The cost of reducing population densities 
through fertility control, with current delivery 
methods, is high (Massei and Cowan 2014). 
As currently approved, hand-injection of 
GonaCon requires the live capture of each 
deer prior to treatment with the vaccine. 
It has been suggested that an effective 
immunocontraceptive for urban and suburban 
deer management ideally should be deliverable 
remotely (Rutberg et al. 2013b). The purpose 
of our research was to: (1) conduct a dart 
configuration assessment trial to determine 
the ideal syringe-dart configuration for 
remote-delivery of GonaCon to white-tailed 
deer and (2) use the determined syringe-dart 
configuration in a subsequent trial to evaluate 
the vaccine efficacy when administered to 




This study was conducted on a 176-ha 
property in southern Connecticut consisting 
of upland deciduous forest with a thick 
understory, wetlands, and open fields. The 
property is enclosed by a 3-m-high chain-link 
fence with 5-cm mesh and surrounded by 
urban development. The deer on the site are 
privately-managed, not exposed to hunting, 
and habituated to human presence. There are 
no individual pens or confinement areas, deer 
on site are free to range within the fence, and no 
supplemental feeding regimes are present. Over 
the past 5 years pregnancy rates of untreated 
adult females have ranged from 92 to 95%, and 
the population has fluctuated between 30 and 
50 individuals. 
Figure 1. One year after the administering GonaConTM, deer 
were euthanized by sharpshooting.
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Dart configuration 
assessment 
Two adult males and adult 
female deer were captured 
under a drop net (Conner et 
al. 1987) and anesthetized by 
injection of Telazol® (4.4 mg/
kg) and xylazine hydrochloride 
(2.2 mg/kg). Each deer received 
an injection of GonaCon in both 
hamstrings and quadriceps 
(4 injections per deer). Ten 
of the 12 injections were 
administered remotely, with 
the deer perpendicular to the 
darter, from a distance of 5 m 
using a gas-based dart projector 
(Figure 1). The syringe-dart 
configurations consisted of 2-cc 
and 1.5-cc, rapid and slow-inject 
(1/3-sec) syringe-darts with 
3.18-cm and 2.54-cm barbless, 
tri-port needles (Pneu-Dart 
Inc., Williamsport, Penn.). We 
included the larger volume syringe-darts 
in the trial to assess whether vaccine dose 
suitable for a larger mammal (e.g., horse [Equus 
caballus]) could be delivered remotely. Two of 
the 12 injections were administered via hand-
injection with 1.5-cc syringes equipped with 
a 2.5-cm and 3.8-cm needle. While still under 
anesthesia, each deer was euthanized with a 
gunshot to the center of the brain. Hind limbs 
were then dissected to reveal the distribution of 
the vaccine deposits (GonaCon is a white and 
viscous vaccine, enabling visual examination of 
distribution). 
Vaccine efficacy trial
Capture. Adult (≥1.5 years) female white-tailed 
deer were captured using drop-nets during February 
and March 2013. Deer were anesthetized by injection 
of Telazol® (4.4 mg/kg) and xylazine hydrochloride 
(2.2 mg/kg) and aged using tooth replacement and 
wear (Severinghaus 1949). Each deer was fitted 
with ear tags (Destron Fearing, St. Paul, Minn.) 
and a VHF radio-collar (Advanced Telemetry 
Systems, Isanti, Minn.) to facilitate locating the 
individual for euthanasia 1 year after capture. All 
deer capture and handling was approved by the 
Institutional Animal Care and Use Committee 
and U.S. Department of Agriculture, Wildlife 
Services, National Wildlife Research Center, 
Quality Assurance Protocol-QA-2075.  
Vaccination. Captured deer were randomly 
assigned to 1 of 2 treatment groups. One group 
was administered GonaCon (1.5 cc) via hand-
injection with 1.5-cc syringes equipped with 
3.81-cm needles administered intramuscularly 
to the upper hind limb via hand-injection 
(Figure 2). The other group while under 
anesthesia received the same dose administered 
by a 1.5 cc slow-inject syringe-dart with a 3.18-
cm barbless, tri-port needle. Deer were darted 
with a gas-based dart projector from a distance 
of 5-m with the deer perpendicular to the 
darter. All darts were examined to determine 
if the entire volume of GonaCon was expelled 
from the dart upon impact. After treatment, the 
reversal agent tolazoline hydrochloride (2.0 mg/
kg IV) was administered and the individuals 
were visually monitored for complications 
with recovery. One year later, deer were located 
and euthanized by sharpshooting techniques as 
described in DeNicola et al. (1997).  
Anti-GnRH antibody titers. Serum 
concentrations of anti-GnRH antibodies can 
be used to estimate immunocontraceptive 
efficacy (Miller et al. 2008). Blood samples 
were collected via cardiac puncture within 1 
Figure 2. Captured deer were randomly assigned to 1 of 2 treatment 
groups. One group was administered GonaConTM  via hand-injection, 
and the other group received GonaCon via syringe-dart delivery.
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minute after death. Serum was isolated via 
centrifugation and then frozen and shipped 
to the National Wildlife Research Center 
(NWRC) in Fort Collins, Colorado. Antibody 
titers were measured using enzyme-linked 
immunosorbent assays as previously described 
(Miller et al. 2008). 
Necropsy. Hind limbs containing the injection 
site were examined externally for abscesses. 
We then necropsied each deer to permit 
internal examination. Presence or absence of 
granulomatous nodules and sterile abscesses 
at the injection site were noted. Presence or 
absence of fetuses were recorded to assess 
pregnancy rates and forehead-rump lengths 
(FRL) were measured on fetuses to determine 
fetal age in days as previously described 
(Hamilton et al. 1985). 
Statistical analysis. All statistical analyses 
were performed using R version 3.1.2 (R Core 
Team, Vienna, Austria, 2015) and significance 
level was set at α = 0.05. We used Fisher’s exact 
test to assess differences between the 2 treatment 
groups in the proportion of deer pregnant. We 
then used the Wilcoxon signed-rank test to 
assess if there was a significant difference in 
titer levels between the 2 treatment groups to 
assess any difference in titer levels between 
pregnant and nonpregnant deer, regardless of 
treatment group.
Results
Dart configuration assessment 
The syringe-darts with 3.18-cm needles 
were retained in the deer frequently, whereas 
the 2.54-cm needles bounced out upon impact 
(Table 1). However, the 3.18-cm needles did not 
retain on 3 occasions. With each dart-injection 
site, there was a substantial amount of vaccine 
that travelled back up the wound channel 
depositing subcutaneously; vaccine left in the 
musculature was dispersed in fascia between 
muscles. Syringe-darts that were not retained 
in the deer deposited most of the vaccine on the 
ground with only a minimal amount deposited 
in the muscle. Hand-injection deposited the 
vaccine in a single bolus in the muscle at the 
depth of the needle.
Vaccine efficacy trial
Thirteen female deer were captured under 
drop nets from February 22 through March 3, 
2013, and treated with the GonaCon vaccine. Six 
females received the vaccine via syringe-dart 
(all darts were retained in the deer) and seven 
via hand-injection (Table 2). Eleven of these 
13 females were euthanized during February 
2014. We were unable to locate 1 female due to 
transmitter failure, and the skeletal remains of 
the other were found during telemetry-assisted 
searches. 
Table 1. Trial data for vaccine deposit results in white-tailed deer with varied inject rates and 
needle lengths of syringe-darts with barbless, tri-port needles and hand-inject syringes.  
Injection Volume (cc) Needle (cm) Dart retention Vaccine deposita
Slow-inject dart 2.0 3.18 Retained VM, VWC
Slow-inject dart 2.0 3.18 Retained VM, VWC
Slow-inject dart 2.0 3.18 Retained VM, VWC
Slow-inject dart 2.0 3.18 Bounced VM, VWC, VG
Slow-inject dart 1.5 3.18 Bounced VM, VWC, VG
Slow-inject dart 1.5 3.18 Retained VM, VWC
Slow-inject dart 1.5 2.54 Bounced VM, VWC, VG
Slow-inject dart 1.5 2.54 Bounced VM, VWC, VG
Rapid-inject dart 2.0 3.18 Bounced VM, VWC, VG
Rapid-inject dart 2.0 3.18 Retained VM, VWC
Hand-inject syringe 1.5 2.54 N/A VM
Hand-inject syringe 1.5 3.81 N/A VM
a VM = vaccine in muscle depth. VWC = vaccine in wound channel; VG = substantial vaccine on 
ground.
269Administering GonaCon™ • Evans et al.
Four of 5 deer treated with syringe-darts were 
pregnant at the time of euthanasia, compared to 
3 of 6 deer that received hand-injections (Table 
2). There was no significant difference between 
treatment groups in proportion pregnant (P 
= 0.54). Two of the females that were treated 
with syringe-darts had twins. The remaining 
pregnant females contained a single fetus. 
Conception was estimated to have occurred 
during the typical November peak breeding 
season, with the exception of 1 female in the 
syringe-dart treatment group that conceived 
mid-January.  
Injection-site reactions ranged from 
concentrated intramuscular granulomas to 
dispersed intramuscular and subcutaneous 
granulomas. Only vaccines administered via 
syringe-dart caused subcutaneous injection site 
reactions; hand-injection caused intramuscular 
reactions only (Table 2). Hand-injection 
reactions resulted in concentrated granulomas 
and abscess masses, with the exception of two, 
which resulted in dispersed intramuscular 
granulomas.
There was no difference in titer levels between 
treatment groups (P = 0.21). However, titer 
levels were strongly correlated with pregnancy 
status. There was a significant difference in 
titer levels between pregnant and nonpregnant 
deer regardless of treatment group (P = 0.02). 
One individual (female #34/9) with an elevated 
titer contained a single fetus (Table 2). All 
other individuals with titers ≥1:64,000 were not 
pregnant; deer with titers <1:10,000 all were 
pregnant. 
Discussion
We found that the efficacy of GonaCon 1-year 
post-administration was less than reported by 
Miller et al. (2008), Gionfriddo et al. (2009), 
and Gionfriddo et al. (2011). This may be 
related to the timing of vaccine delivery. In 
the aforementioned trials, deer were treated 
in July and August (2 to 4 months prior to the 
breeding season), whereas females in our trial 
were treated in February and March (8 months 
prior to the breeding season), which may have 
resulted in reduced titer levels at the time of the 
breeding season. 
We saw comparable results with regards 
to vaccine dispersal during the initial dart 
configuration assessment and the efficacy trial. 
Table 2. Treatment data for white-tailed deer in the hand-inject versus dart-delivery GonaConTM trial, 
treated February 22 - March 3, 2013 and euthanized for necropsy February 2014.
Treatment 
group
Tag number Age (years) 
2013





Hand 34R/9L 2 1:128,000 Yes 1 fetus Concentrated IM
Hand 181/181 7 1:128,000 Yes NP Slightly dispersed IM
Hand 8R/7L 7 1:128,000 Yes NP Concentrated IM
Hand 47R/48L 4 1:64,000 Yes NP Concentrated IM
Hand 42R/37L 5 1:2,000 Yes 1 fetus Slightly dispersed IM
Hand 43R/44L 9 0 Yes 1 fetus Concentrated IM
Hand 55R/20L 7 – – TF –
Dart 41R/40L 6 1:128,000 Yes NP Subcutaneous—
dispersed IM
Dart 19R/21L 8 1:8,000 Yes 1 fetus Small subcutaneous— 
concentrated IM
Dart 32R/33L 2 0 Yes 1 fetus Small subcutaneous 
—dispersed IM
Dart 35R/36L 6 0 Yes 2 fetuses Subcutaneous—small 
IM
Dart 18R/17L 2 0 Yes 2 fetuses Small subcutaneous— 
dispersed IM
Dart 50R/52L 8 – – MS –
a IM = intramuscular; NP = not pregnant; TF = transmitter failure; MS = mortality signal.
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In both trials, the syringe-dart resulted in a 
substantial amount of vaccine traveling back 
up the wound channel while hand-injections 
resulted in the vaccine deposited in a single 
bolus. In general, the hand-injection reaction 
sites had a larger concentrated granuloma and 
abscess confined within the muscle, whereas 
the syringe-dart injection sites displayed a 
more dispersed granuloma in the muscle plus 
some subcutaneous reaction areas. Gionfriddo 
et al. (2011) suggested that the formation 
of granulomas at injection sites may be an 
essential aspect of a strong immune response 
that induces infertility in GonaCon-treated 
animals. From our observations, the body can 
better compartmentalize the dispersed vaccine 
resulting in small granulomas and may reduce 
immune response. The larger bolus deposit of 
the hand-injected vaccine resulted in localized 
granulomas and abscesses that likely extend the 
exposure of the vaccine to the immune system, 
thus, increasing the efficacy. The significant 
difference in antibody titer between pregnant 
and nonpregnant animals supports the findings 
by Miller et al. (2000) of a titer level ≥1:64,000 
is sufficient to suppress fertility in white-tailed 
deer. 
Management implications
Given the performance of the vaccine 
coupled with remote-injection, we question 
whether syringe-dart delivery of GonaCon 
is an appropriate management tool at this 
time. The lack of a statistically significant 
difference in contraceptive efficacy between 
the 2 treatments may be due to a small sample 
size. We recommend further research on the 
development of this technique with a larger 
sample size. GonaCon may perform better 
when hand-injected as a single bolus, limiting 
the dispersion of the vaccine and amount exiting 
the wound channel. Research should include 
the use of different needle barbing and porting 
techniques, such as various configurations of 
gelatin-barbs and 3.8-cm, tri-port needles. The 
gelatin-barb and longer needle will more likely 
ensure complete delivery of the vaccine into the 
deep musculature of the individual similar to 
hand-injection. A gelatin-barb, smaller than the 
conventional size, may be adequate for single-
bolus injection without compromising dart 
recovery. We recommend using 2.0-cc darts 
so that an additional 0.5 cc per required dose 
may be administered to compensate for the 
vaccine that may travel out the wound channel. 
This design will need to be accompanied by a 
slow injection rate (e.g., 1 second) for a more 
controlled vaccine deposit, similar to a hand-
injection. Future trials should be conducted 
with similar timing to our trial (January 
through March) to further test the vaccine 
efficacy when administered during optimal 
months for capture and darting (i.e., when bait 
leverage is high and there is no foliage on trees 
to compromise darting opportunities). 
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